PER 34.1% 8.9¢ percheron therapeutics limited

We hope there is competition RYN, management have moderated...

  1. 4,710 Posts.
    lightbulb Created with Sketch. 1097
    We hope there is competition RYN, management have moderated their deal size expectation in recent presos.

    The Roche $1B+ deal with Sarepta for GT in DMD is not being mentioned in recent presentations.

    The median deal size in the table of recent deals looks a bit meh!

    All eyes on full recruitment and the burn down clock to 6 months...
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.